Author: et

HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus

HONG KONG, Oct 31, 2025 – (ACN Newswire via SeaPRwire.com) – HighTide Therapeutics, Inc. (2511.HK), a biopharmaceutical company specializing in the development of multifunctional, multi-targeted therapies for chronic metabolic diseases, announced positive 52-week safety and efficacy results from the open-label extension

More

OTS Holdings Celebrates the Grand Opening of its New Manufacturing Facility, Ellaziq (Malaysia) Sdn. Bhd., in Johor, Malaysia; Marks Major Expansion in its Halal Production Capacity

SINGAPORE, Oct 29, 2025 – (ACN Newswire via SeaPRwire.com) – OTS Holdings Limited (“OTS Holdings” or the “Company”, and together with its subsidiaries, the “Group”), a brand builder and food manufacturing group, is pleased to announce the grand opening of

More

GTJAI Serves as the Sole Sponsor for CIG, Achieving the Largest IPO in the Telecommunications Equipment Sector across Both A-shares and H-shares Markets

HONG KONG, Oct 29, 2025 – (ACN Newswire via SeaPRwire.com) – October 28, As the sole sponsor, sponsor-overall coordinator, overall coordinator, joint global coordinator, joint bookrunner and joint lead manager, Guotai Junan International Holdings Limited (“GTJAI” or “the Company”, stock

More